C-Kit point mutations in core binding factor leukemias:: correlation with white blood cell count and the white blood cell index

被引:31
作者
Cairoli, R
Grillo, G
Beghini, A
Tedeschi, A
Ripamonti, CB
Larizza, L
Morra, E
机构
[1] Osped Niguarda Ca Granda, Div Ematol, Milan, Italy
[2] Univ Milan, Fac Med, Dept Biol & Genet, Milan, Italy
关键词
D O I
10.1038/sj.leu.2402795
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:471 / 472
页数:2
相关论文
共 9 条
  • [1] C-kit mutations in core binding factor leukemias
    Beghini, A
    Peterlongo, P
    Ripamonti, CB
    Larizza, L
    Cairoli, R
    Morra, E
    Mecucci, C
    [J]. BLOOD, 2000, 95 (02) : 726 - 727
  • [2] In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent c-kit mutation
    Beghini, A
    Cairoli, R
    Morra, E
    Larizza, L
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (12) : 262 - 270
  • [3] c-kit activating mutations and mast cell proliferation in human leukemia
    Beghini, A
    Larizza, L
    Cairoli, R
    Morra, E
    [J]. BLOOD, 1998, 92 (02) : 701 - 702
  • [4] c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia
    Gari, M
    Goodeve, A
    Wilson, G
    Winship, P
    Langabeer, S
    Linch, D
    Vandenberghe, E
    Peake, I
    Reilly, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) : 894 - 900
  • [5] Kiyoi H, 1999, BLOOD, V93, P3074
  • [6] A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML):: a survey of 161 cases from the French AML Intergroup
    Nguyen, S
    Leblanc, T
    Fenaux, P
    Witz, F
    Blaise, D
    Pigneux, A
    Thomas, X
    Rigal-Huguet, F
    Lioure, B
    Auvrignon, A
    Fière, D
    Reiffers, J
    Castaigne, S
    Leverger, G
    Harousseau, JL
    Socié, G
    Dombret, H
    [J]. BLOOD, 2002, 99 (10) : 3517 - 3523
  • [7] Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone
    Schlenk, RF
    Dohner, H
    Pforsich, M
    Benner, A
    Fischer, K
    Hartman, F
    Fischer, JT
    Weber, W
    Gunzer, U
    Pralle, H
    Haas, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 386 - 393
  • [8] Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
    Schnittger, S
    Schoch, C
    Dugas, M
    Kern, W
    Staib, P
    Wuchter, C
    Löffler, H
    Sauerland, CM
    Serve, H
    Büchner, T
    Haferlach, T
    Hiddemann, W
    [J]. BLOOD, 2002, 100 (01) : 59 - 66
  • [9] Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
    Thiede, C
    Steudel, C
    Mohr, B
    Schaich, M
    Schäkel, U
    Platzbecker, U
    Wermke, M
    Bornhäuser, M
    Ritter, M
    Neubauer, A
    Ehninger, G
    Illmer, T
    [J]. BLOOD, 2002, 99 (12) : 4326 - 4335